PLRX - Dinamika pendapatan YoY sajrone rolas wulan kepungkur Pliant Therapeutics

Logo grafis pliantrx.com (PLRX)

Pliant Therapeutics (PLRX) currently generates no revenue, remaining dependent on Bexotegrast trials. This daily chart of trailing twelve-month revenue changes from the GURU.Markets service reflects a trend where the level 0.00 represents the current value. High FDA barriers and patents protect the business, while its status as a scientific leader in pulmonary fibrosis therapy provides the company with impeccable authority among specialized physicians.

PLRX Pliant Therapeutics: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 18.11.2026

Pliant Therapeutics Inc (PLRX) - rincian metrik lan laporan keuangan

- rega saham lan konsensus proyeksi valuasi:
Analisis kabeh metrik perusahaan:Pliant Therapeutics, Inc., PLRX
Produk seri Pliant Therapeutics, Inc.

Pliant Therapeutics (PLRX) develops selective integrin inhibitors to combat fibrosis, possessing significant pricing power. The rolling year-over-year revenue dynamics allow for a real-time assessment of the commercialization of these drugs. This metric measures the pace of sales expansion by comparing the current twelve months to the same period last year. An increase in the indicator confirms business scaling, while a decline signals weakening demand. By analyzing the relative change in rolling year-over-year revenue, an investor can observe actual market expansion.

Pesaing Pliant Therapeutics (PLRX)

VRTX (Vertex Pharmaceuticals Inc.) - Wutah dodolan taun lumaku|Alnylam Pharmaceuticals - Wutah dodolan YoY (TTM)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur INSM (Insmed Incorporated)|UTHR: Wutah dodolan YoY (TTM)|BioMarin Pharmaceutical Inc. (BMRN) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY sajrone rolas wulan kepungkur BridgeBio Pharma Inc|Wutah pendapatan YoY sajrone 12 wulan kepungkur BGM Group Ltd (BGM)|Wutah dodolan YoY sajrone rolas wulan kepungkur cogentbio.com (COGT)|Wutah pendapatan YoY sajrone 12 wulan kepungkur Xeris Biopharma XERS|Wutah dodolan YoY (TTM) KROS (kerostx.com)|Wutah dodolan YoY (TTM) Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah dodolan YoY (TTM)|KMDA - Wutah dodolan YoY (TTM)|FULC (Fulcrum Corp) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|ABEO (Abeona Therapeutics, Inc.) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Applied Therapeutics (APLT)|Rein Therapeutics Inc - Wutah dodolan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY (TTM) GELS (Gelteq)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur AYTU|CMMB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku srxhealth.com|PLRZ (Polyrizon) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Aeterna Zentaris (AEZS) - Wutah dodolan YoY (TTM)|CYTH (Cyclo Therapeutics) - Wutah dodolan YoY (TTM)|INZY: Dinamika pendapatan YoY sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) RPHM|CSCI (COSCIENS Biopharma) - Dinamika pendapatan YoY sajrone rolas wulan kepungkur